Zhejiang Raybow and Raybow (Suzhou) Achieve CDP A-List Ratings


Release time:

2026-02-04

Recently, Zhejiang Raybow Pharmaceutical Co., Ltd. and Raybow (Suzhou) Pharmaceutical Co., Ltd., subsidiaries of Zhejiang JiuZhou Pharma Co., Ltd., updated their annual ratings on CDP (the global environmental disclosure platform). Both companies delivered outstanding performance, demonstrating internationally leading environmental management capabilities.

About CDP
CDP operates a global, independent environmental disclosure system. CDP ratings are widely recognized as the global “gold standard” for corporate environmental transparency and environmental management, covering three key environmental themes: climate change, water security, and forests.
In 2025, more than 22,100 companies reported environmental data through CDP, with nearly 20,000 companies receiving scores. CDP works with over 640 institutional investors—representing USD 127 trillion in assets under management—as well as hundreds of purchasing organizations, leveraging the influence of investors and buyers to encourage companies to disclose and manage their environmental impacts.

Safeguarding the Source of Life: The Path to Double-A Water Security
The companies have implemented a systematic approach to water-risk management, including comprehensive assessments of water use, diversification of water sources, and robust water-saving and recycling initiatives, continuously improving water-use efficiency. In parallel, they have advanced process optimization and upgraded reclaimed-water reuse and wastewater treatment technologies, achieving a steady reduction in water-use intensity and promoting harmonious coexistence between operations and regional aquatic ecosystems.

Climate Action: Toward a Net-Zero Future
In the area of climate change, the companies have established a science-based climate risk management framework and obtained Science Based Targets initiative (SBTi) validation. Through the adoption of green chemistry, optimization of the energy mix, improvements in energy efficiency, and expanded use of clean energy, they continue to drive the effective implementation of emissions-reduction goals.

Other News

Zhejiang Raybow and Raybow (Suzhou) Achieve CDP A-List Ratings

Recently, Zhejiang Raybow Pharmaceutical Co., Ltd. and Raybow (Suzhou) Pharmaceutical Co., Ltd., subsidiaries of Zhejiang JiuZhou Pharma Co., Ltd., updated their annual ratings on CDP (the global environmental disclosure platform). Both companies delivered outstanding performance, demonstrating internationally leading environmental management capabilities.

About CDP
CDP operates a global, independent environmental disclosure system. CDP ratings are widely recognized as the global “gold standard” for corporate environmental transparency and environmental management, covering three key environmental themes: climate change, water security, and forests.
In 2025, more than 22,100 companies reported environmental data through CDP, with nearly 20,000 companies receiving scores. CDP works with over 640 institutional investors—representing USD 127 trillion in assets under management—as well as hundreds of purchasing organizations, leveraging the influence of investors and buyers to encourage companies to disclose and manage their environmental impacts.

Safeguarding the Source of Life: The Path to Double-A Water Security
The companies have implemented a systematic approach to water-risk management, including comprehensive assessments of water use, diversification of water sources, and robust water-saving and recycling initiatives, continuously improving water-use efficiency. In parallel, they have advanced process optimization and upgraded reclaimed-water reuse and wastewater treatment technologies, achieving a steady reduction in water-use intensity and promoting harmonious coexistence between operations and regional aquatic ecosystems.

Climate Action: Toward a Net-Zero Future
In the area of climate change, the companies have established a science-based climate risk management framework and obtained Science Based Targets initiative (SBTi) validation. Through the adoption of green chemistry, optimization of the energy mix, improvements in energy efficiency, and expanded use of clean energy, they continue to drive the effective implementation of emissions-reduction goals.

2026-02-04

Dr. Kai Rossen of JiuZhou Pharma Officially Joins the International Advisory Board of Angewandte Chemie

Recently, Zhejiang Raybow Pharmaceutical Co., Ltd. and Raybow (Suzhou) Pharmaceutical Co., Ltd., subsidiaries of Zhejiang JiuZhou Pharma Co., Ltd., updated their annual ratings on CDP (the global environmental disclosure platform). Both companies delivered outstanding performance, demonstrating internationally leading environmental management capabilities.

About CDP
CDP operates a global, independent environmental disclosure system. CDP ratings are widely recognized as the global “gold standard” for corporate environmental transparency and environmental management, covering three key environmental themes: climate change, water security, and forests.
In 2025, more than 22,100 companies reported environmental data through CDP, with nearly 20,000 companies receiving scores. CDP works with over 640 institutional investors—representing USD 127 trillion in assets under management—as well as hundreds of purchasing organizations, leveraging the influence of investors and buyers to encourage companies to disclose and manage their environmental impacts.

Safeguarding the Source of Life: The Path to Double-A Water Security
The companies have implemented a systematic approach to water-risk management, including comprehensive assessments of water use, diversification of water sources, and robust water-saving and recycling initiatives, continuously improving water-use efficiency. In parallel, they have advanced process optimization and upgraded reclaimed-water reuse and wastewater treatment technologies, achieving a steady reduction in water-use intensity and promoting harmonious coexistence between operations and regional aquatic ecosystems.

Climate Action: Toward a Net-Zero Future
In the area of climate change, the companies have established a science-based climate risk management framework and obtained Science Based Targets initiative (SBTi) validation. Through the adoption of green chemistry, optimization of the energy mix, improvements in energy efficiency, and expanded use of clean energy, they continue to drive the effective implementation of emissions-reduction goals.

2026-02-02

How Do Small Molecule APIs Support Continuous Innovation in the Pharmaceutical Industry

Recently, Zhejiang Raybow Pharmaceutical Co., Ltd. and Raybow (Suzhou) Pharmaceutical Co., Ltd., subsidiaries of Zhejiang JiuZhou Pharma Co., Ltd., updated their annual ratings on CDP (the global environmental disclosure platform). Both companies delivered outstanding performance, demonstrating internationally leading environmental management capabilities.

About CDP
CDP operates a global, independent environmental disclosure system. CDP ratings are widely recognized as the global “gold standard” for corporate environmental transparency and environmental management, covering three key environmental themes: climate change, water security, and forests.
In 2025, more than 22,100 companies reported environmental data through CDP, with nearly 20,000 companies receiving scores. CDP works with over 640 institutional investors—representing USD 127 trillion in assets under management—as well as hundreds of purchasing organizations, leveraging the influence of investors and buyers to encourage companies to disclose and manage their environmental impacts.

Safeguarding the Source of Life: The Path to Double-A Water Security
The companies have implemented a systematic approach to water-risk management, including comprehensive assessments of water use, diversification of water sources, and robust water-saving and recycling initiatives, continuously improving water-use efficiency. In parallel, they have advanced process optimization and upgraded reclaimed-water reuse and wastewater treatment technologies, achieving a steady reduction in water-use intensity and promoting harmonious coexistence between operations and regional aquatic ecosystems.

Climate Action: Toward a Net-Zero Future
In the area of climate change, the companies have established a science-based climate risk management framework and obtained Science Based Targets initiative (SBTi) validation. Through the adoption of green chemistry, optimization of the energy mix, improvements in energy efficiency, and expanded use of clean energy, they continue to drive the effective implementation of emissions-reduction goals.

2026-01-12

Business Collaboration

Innovative Drug CDMO Services

Established Business Services(API)

Human Resources

Join Us

Jiuzhou

LinkedIn

License

Powered by 300.cn